Condition: Langerhans Cell Histiocytosis · LCH · Sponsor: Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd.
This is a rare disease, single-arm, open-label,multi-center, non-randomized Phase 2 clinical study to evaluate the efficacy, safety, and pharmacokinetic characteristics of FCN-159 monotherapy in pediatric patients with refractory/recurrent Langerhans cell histiocytosis (LCH).
This description comes directly from the study's public registry record.
Rui Zhang, MD · 18611106187 · ruizh1973@126.com
Always discuss trial participation with your own doctor first.
| Beijing Children's Hospital, Capital Medical University | Beijing, Beijing Municipality, China | Recruiting |
| Children's Hospital Affiliated to the Capital Institute of Pediatrics | Beijing, Beijing Municipality, China | Not Yet Recruiting |
| Children's Hospital of Chongqing Medical University | Chongqing, Chongqing Municipality, China | Recruiting |
| Sun Yat-Sen Memorial Hpsipital,Sun Yat-Sen Unniversity | Guangzhou, Guangdong, China | Not Yet Recruiting |
| The First Affiliated Hospital,Sun Yat-sen University | Guangzhou, Guangdong, China | Not Yet Recruiting |
| Shenzhen Children's Hospital | Shenzhen, Guangdong, China | Not Yet Recruiting |
| Henan Children's Hospital Zhengzhou Children's Hospital | Zhengzhou, Henan, China | Not Yet Recruiting |
| Tongji Hospital Affiliated to Tongji Medical College of Huazhong University of Science and Technology | Wuhan, Hubei, China | Not Yet Recruiting |
| West China Second University Hospital,Sihuan University/West China women's and Children's Hospital | Chengdu, Sichuan, China | Not Yet Recruiting |
| Children's Hospital, Zhejiang University School of Medicine | Hangzhou, Zhejiang, China | Not Yet Recruiting |
| Children's Hospital of Soochow University | Suzhou, China | Not Yet Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05997602